U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 391

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr10:43615538
GRCh38:
Chr10:43120090
RETR390W, R438W, R478W, R529W, R531W, R534W, R543W, R574W, R619W, R631W, R698W, R727W, R741W, R777W, R785W, R828W, R830W, R873WHereditary cancer-predisposing syndrome, Hirschsprung disease, susceptibility to, 1Likely pathogenic
(May 18, 2023)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr10:43608412
GRCh38:
Chr10:43112964
RETHirschsprung disease, susceptibility to, 1Likely pathogenic
(Jul 15, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr10:43606914
GRCh38:
Chr10:43111466
RETHirschsprung disease, susceptibility to, 1Likely pathogenic
(May 26, 2020)
criteria provided, single submitter
4.
GRCh37:
Chr10:43606829
GRCh38:
Chr10:43111381
RETE150*, E226*, E238*, E305*, E334*, E348*, E384*, E437*, E480*Hirschsprung disease, susceptibility to, 1Likely pathogenic
(Jul 13, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr10:43610186
GRCh38:
Chr10:43114738
RETHirschsprung disease, susceptibility to, 1, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Mar 28, 2022)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr10:43595991
GRCh38:
Chr10:43100543
RETV53AHirschsprung disease, susceptibility to, 1Uncertain significance
(Jan 13, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr10:43600359
GRCh38:
Chr10:43104911
RETnot specified, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma
Likely benign
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr10:43615019
GRCh38:
Chr10:43119571
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Hirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a
Likely benign
(Jun 16, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr10:43609141
GRCh38:
Chr10:43113693
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a
Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr10:43601806
GRCh38:
Chr10:43106358
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a
Likely benign
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr10:43604697
GRCh38:
Chr10:43109249
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a
Likely benign
(Jun 21, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr10:43600584
GRCh38:
Chr10:43105136
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b,
Pheochromocytoma, Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2a
Likely benign
(Apr 24, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr10:43612194
GRCh38:
Chr10:43116746
RETMultiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2
Likely benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr10:43619269
GRCh38:
Chr10:43123821
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a
Likely benign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr10:43572796
GRCh38:
Chr10:43077348
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a
Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr10:43607686
GRCh38:
Chr10:43112238
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a
Likely benign
(Feb 4, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr10:43598088
GRCh38:
Chr10:43102640
RETMultiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2
Likely benign
(Aug 28, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr10:43604645
GRCh38:
Chr10:43109197
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2
Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr10:43615066
GRCh38:
Chr10:43119618
RETL827P, L573P, L344P, L392P, L528P, L652P, L739P, L784P, L483P, L488P, L681P, L432P, L585P, L695P, L731P, L485P, L497P, L782PMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Hirschsprung disease, susceptibility to, 1,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Pheochromocytoma
Uncertain significance
(Mar 18, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr10:43598044
GRCh38:
Chr10:43102596
RETP198S, P155SHirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2b,
Multiple endocrine neoplasia, type 2a, Pheochromocytoma, Multiple endocrine neoplasia, type 2
Uncertain significance
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr10:43622157
GRCh38:
Chr10:43126709
RETE1058D, E804D, E714D, E728D, E926D, E962D, E1013D, E1015D, E663D, E816D, E883D, E623D, E716D, E719D, E759D, E970D, E575D, E912DMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Hirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a
Uncertain significance
(Dec 12, 2021)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr10:43609073
GRCh38:
Chr10:43113625
RETN610S, N356S, N215S, N268S, N478S, N567S, N127S, N280S, N311S, N514S, N368S, N435S, N464SHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia, type 2a
Uncertain significance
(Apr 13, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr10:43622162
GRCh38:
Chr10:43126714
RETK806R, K1060R, K1015R, K625R, K718R, K761R, K885R, K972R, K716R, K721R, K818R, K964R, K1017R, K577R, K914R, K928R, K665R, K730RHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b,
Hirschsprung disease, susceptibility to, 1, Pheochromocytoma, Multiple endocrine neoplasia, type 2a,
Familial medullary thyroid carcinoma
Uncertain significance
(Feb 11, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr10:43606650
GRCh38:
Chr10:43111202
RETnot provided, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b,
Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Nov 3, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr10:43615073
GRCh38:
Chr10:43119625
RETMultiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2
Likely benign
(Feb 5, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr10:43601916
GRCh38:
Chr10:43106468
RETHereditary cancer-predisposing syndrome, Hirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Multiple endocrine neoplasia, type 2a,
not specified, Multiple endocrine neoplasia, type 2
Benign/Likely benign
(Aug 4, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr10:43615621
GRCh38:
Chr10:43120173
RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, Hirschsprung disease, susceptibility to, 1,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Multiple endocrine neoplasia, type 2a
Likely benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr10:43607641
GRCh38:
Chr10:43112193
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a
Likely benign
(Nov 24, 2021)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr10:43620376
GRCh38:
Chr10:43124928
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a
Likely benign
(Jun 3, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr10:43601854
GRCh38:
Chr10:43106406
RETD300N, D46N, D204N, D257NHirschsprung disease, susceptibility to, 1Uncertain significance
(Aug 6, 2020)
criteria provided, single submitter
31.
GRCh37:
Chr10:43598017
GRCh38:
Chr10:43102569
RETR189C, R146CHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Pheochromocytoma,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2b
Uncertain significance
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr10:43597896-43597898
GRCh38:
Chr10:43102448-43102450
RETF150delHirschsprung disease, susceptibility to, 1, Pheochromocytoma, Familial medullary thyroid carcinoma,
Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2b, Multiple endocrine neoplasia, type 2,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Aug 18, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr10:43609072
GRCh38:
Chr10:43113624
RETN356H, N610H, N280H, N464H, N127H, N215H, N268H, N435H, N478H, N514H, N311H, N368H, N567HHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Aug 28, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr10:43622107
GRCh38:
Chr10:43126659
RETD1042N, D788N, D559N, D698N, D954N, D999N, D647N, D700N, D703N, D743N, D800N, D896N, D910N, D946N, D607N, D712N, D867N, D997NMultiple endocrine neoplasia, type 2, Pheochromocytoma, Hirschsprung disease, susceptibility to, 1,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2b
Uncertain significance
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr10:43597904
GRCh38:
Chr10:43102456
RETN151IHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Pheochromocytoma,
Hirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Multiple endocrine neoplasia, type 2b
Uncertain significance
(Apr 16, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr10:43596032
GRCh38:
Chr10:43100584
RETR67GHirschsprung disease, susceptibility to, 1Uncertain significance
(Feb 23, 2020)
criteria provided, single submitter
37.
GRCh37:
Chr10:43620422
GRCh38:
Chr10:43124974
RETK757E, K1011E, K712E, K865E, K879E, K923E, K528E, K576E, K669E, K672E, K681E, K769E, K966E, K836E, K915E, K968E, K616E, K667EHereditary cancer-predisposing syndrome, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Multiple endocrine neoplasia, type 2
Uncertain significance
(Apr 4, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr10:43622027
GRCh38:
Chr10:43126579
RETY761C, Y1015C, Y673C, Y773C, Y869C, Y883C, Y919C, Y671C, Y840C, Y972C, Y532C, Y580C, Y676C, Y685C, Y927C, Y970C, Y620C, Y716CHereditary cancer-predisposing syndrome, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Multiple endocrine neoplasia, type 2
Uncertain significance
(Jun 16, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr10:43600451
GRCh38:
Chr10:43105003
RETR226P, R130P, R183PMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Multiple endocrine neoplasia, type 2b
Uncertain significance
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr10:43610126
GRCh38:
Chr10:43114678
RETR693H, R439H, R451H, R648H, R650H, R351H, R363H, R394H, R547H, R605H, R210H, R298H, R597H, R258H, R349H, R354H, R518H, R561HMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, Familial medullary thyroid carcinoma,
Pheochromocytoma, Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2b,
Hirschsprung disease, susceptibility to, 1
Uncertain significance
(Nov 29, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr10:43606776
GRCh38:
Chr10:43111328
RETS462L, S208L, S132L, S366L, S287L, S316L, S419L, S220L, S330LHereditary cancer-predisposing syndrome, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Hirschsprung disease, susceptibility to, 1,
Ovarian cancer, Multiple endocrine neoplasia, type 2
Conflicting interpretations of pathogenicity
(Oct 8, 2022)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr10:43572765
GRCh38:
Chr10:43077317
RETP20QHereditary cancer-predisposing syndrome, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Multiple endocrine neoplasia, type 2
Uncertain significance
(May 17, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr10:43622123
GRCh38:
Chr10:43126675
RETP1047L, P793L, P1004L, P564L, P612L, P872L, P705L, P748L, P805L, P901L, P1002L, P652L, P717L, P915L, P951L, P703L, P708L, P959LHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Pheochromocytoma,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2b
Uncertain significance
(Mar 7, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr10:43600524
GRCh38:
Chr10:43105076
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma,
Multiple endocrine neoplasia, type 2a
Conflicting interpretations of pathogenicity
(Aug 18, 2022)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr10:43601916
GRCh38:
Chr10:43106468
RETHereditary cancer-predisposing syndrome, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Multiple endocrine neoplasia, type 2b, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia, type 2
Conflicting interpretations of pathogenicity
(Jul 19, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr10:43625233
GRCh38:
Chr10:43129785
RETHirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, Pheochromocytoma,
Renal hypodysplasia/aplasia 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr10:43623897
GRCh38:
Chr10:43128449
RETHirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, Pheochromocytoma,
Renal hypodysplasia/aplasia 1
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
48.
GRCh37:
Chr10:43625617
GRCh38:
Chr10:43130169
RETHirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, Pheochromocytoma,
Renal hypodysplasia/aplasia 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr10:43624829
GRCh38:
Chr10:43129381
RETHirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, Pheochromocytoma,
Renal hypodysplasia/aplasia 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr10:43623876
GRCh38:
Chr10:43128428
RETHirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1, Multiple endocrine neoplasia,
Pheochromocytoma
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
51.
GRCh37:
Chr10:43572656
GRCh38:
Chr10:43077208
LOC106736614, RETHirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1, Pheochromocytoma,
Multiple endocrine neoplasia
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr10:43625603
GRCh38:
Chr10:43130155
RETHirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1, Pheochromocytoma,
Multiple endocrine neoplasia
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr10:43625147
GRCh38:
Chr10:43129699
RETMultiple endocrine neoplasia, not provided, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Renal hypodysplasia/aplasia 1
Conflicting interpretations of pathogenicity
(Jan 1, 2023)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr10:43624763
GRCh38:
Chr10:43129315
RETMultiple endocrine neoplasia, not provided, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Renal hypodysplasia/aplasia 1
Conflicting interpretations of pathogenicity
(Mar 1, 2023)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr10:43624217
GRCh38:
Chr10:43128769
RETHirschsprung disease, susceptibility to, 1, Pheochromocytoma, Renal hypodysplasia/aplasia 1,
Multiple endocrine neoplasia
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
56.
GRCh37:
Chr10:43606717
GRCh38:
Chr10:43111269
RETRenal hypodysplasia/aplasia 1, Multiple endocrine neoplasia, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr10:43600645
GRCh38:
Chr10:43105197
RETHirschsprung disease, susceptibility to, 1, Pheochromocytoma, Renal hypodysplasia/aplasia 1,
Multiple endocrine neoplasia
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr10:43572547
GRCh38:
Chr10:43077099
LOC106736614, RETRenal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia
Benign/Likely benign
(Jul 18, 2017)
criteria provided, single submitter
59.
GRCh37:
Chr10:43572534
GRCh38:
Chr10:43077086
LOC106736614, RETPheochromocytoma, Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr10:43625529
GRCh38:
Chr10:43130081
RETPheochromocytoma, Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr10:43625250
GRCh38:
Chr10:43129802
RETHirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1, Pheochromocytoma,
Multiple endocrine neoplasia
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr10:43625043
GRCh38:
Chr10:43129595
RETHirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1, Pheochromocytoma,
Multiple endocrine neoplasia
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
63.
GRCh37:
Chr10:43624600
GRCh38:
Chr10:43129152
RETHirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1, Pheochromocytoma,
Multiple endocrine neoplasia
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr10:43624209
GRCh38:
Chr10:43128761
RETRenal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia
Benign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr10:43623746
GRCh38:
Chr10:43128298
RETMultiple endocrine neoplasia, Hirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1,
not specified, Pheochromocytoma
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr10:43609923
GRCh38:
Chr10:43114475
RETHereditary cancer-predisposing syndrome, Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Multiple endocrine neoplasia
Uncertain significance
(May 10, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr10:43607625
GRCh38:
Chr10:43112177
RETL534P, L280P, L359P, L402P, L491P, L192P, L235P, L438P, L51P, L139P, L204P, L292P, L388PHereditary cancer-predisposing syndrome, Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Multiple endocrine neoplasia
Uncertain significance
(Jun 15, 2021)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr10:43615550
GRCh38:
Chr10:43120102
RETA877P, A623P, A535P, A538P, A781P, A789P, A635P, A702P, A731P, A745P, A394P, A547P, A578P, A442P, A482P, A533P, A832P, A834PHirschsprung disease, susceptibility to, 1Likely pathogenic
(Aug 24, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr10:43596011
GRCh38:
Chr10:43100563
RETP60SMultiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia, type 2b, Familial medullary thyroid carcinoma, Hereditary cancer-predisposing syndrome,
Multiple endocrine neoplasia, type 2
Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr10:43609055
GRCh38:
Chr10:43113607
RETA350V, A604V, A305V, A362V, A458V, A561V, A274V, A472V, A121V, A209V, A262V, A429V, A508VMultiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia, type 2b, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2
Uncertain significance
(Apr 3, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr10:43597895
GRCh38:
Chr10:43102447
RETS148FHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma
Uncertain significance
(Jul 8, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr10:43623564
GRCh38:
Chr10:43128116
RETM1064IHereditary cancer-predisposing syndrome, not provided, Multiple endocrine neoplasia, type 2,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a
Conflicting interpretations of pathogenicity
(Dec 29, 2022)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr10:43602018
GRCh38:
Chr10:43106570
RETMultiple endocrine neoplasia, type 2, Pheochromocytoma, Hirschsprung disease, susceptibility to, 1,
Renal hypodysplasia/aplasia 1, Multiple endocrine neoplasia
Uncertain significance
(Sep 30, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr10:43606645
GRCh38:
Chr10:43111197
RETMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1
Uncertain significance
(Apr 5, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr10:43622167
GRCh38:
Chr10:43126719
RETY1062H, Y808H, Y1017H, Y718H, Y723H, Y930H, Y974H, Y579H, Y732H, Y763H, Y916H, Y1019H, Y627H, Y667H, Y887H, Y720H, Y820H, Y966HHirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hereditary cancer-predisposing syndrome,
Multiple endocrine neoplasia, type 2
Uncertain significance
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr10:43601846
GRCh38:
Chr10:43106398
RETR43H, R297H, R201H, R254HHirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hereditary cancer-predisposing syndrome,
Multiple endocrine neoplasia, type 2
Uncertain significance
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr10:43615036
GRCh38:
Chr10:43119588
RETR563H, R817H, R382H, R478H, R487H, R575H, R642H, R334H, R475H, R685H, R518H, R671H, R729H, R772H, R422H, R473H, R721H, R774HMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2a,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Sep 28, 2021)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr10:43613822
GRCh38:
Chr10:43118374
RETE762D, E508D, E418D, E420D, E520D, E327D, E423D, E587D, E666D, E279D, E367D, E463D, E630D, E674D, E717D, E432D, E616D, E719DHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma,
Multiple endocrine neoplasia, type 2a
Uncertain significance
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr10:43606754
GRCh38:
Chr10:43111306
RETV201I, V455I, V213I, V280I, V412I, V309I, V323I, V359I, V125IHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma,
Multiple endocrine neoplasia, type 2a
Uncertain significance
(Sep 21, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr10:43596019
GRCh38:
Chr10:43100571
RETMultiple endocrine neoplasia, type 2b, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2
Likely benign
(Mar 23, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr10:43600497
GRCh38:
Chr10:43105049
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma, Multiple endocrine neoplasia, type 2a, Familial medullary thyroid carcinoma,
Multiple endocrine neoplasia, type 2b
Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr10:43595971
GRCh38:
Chr10:43100523
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1,
Pheochromocytoma
Likely benign
(Mar 9, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr10:43608294
GRCh38:
Chr10:43112846
RETMultiple endocrine neoplasia, type 2, Pheochromocytoma, Multiple endocrine neoplasia, type 2b,
Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma
Likely benign
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr10:43606702
GRCh38:
Chr10:43111254
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Familial medullary thyroid carcinoma,
Pheochromocytoma, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2b
Likely benign
(Apr 19, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr10:43610137
GRCh38:
Chr10:43114689
RETHirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Multiple endocrine neoplasia, type 2,
Hereditary cancer-predisposing syndrome
Likely benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr10:43600599
GRCh38:
Chr10:43105151
RETHirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Hereditary cancer-predisposing syndrome,
not provided, Multiple endocrine neoplasia, type 2
Likely benign
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr10:43600486
GRCh38:
Chr10:43105038
RETE238*, E142*, E195*Hirschsprung disease, susceptibility to, 1Pathogenic
(Sep 27, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr10:43609124
GRCh38:
Chr10:43113676
RETnot provided, Hirschsprung disease, susceptibility to, 1Pathogenic/Likely pathogenic
(Dec 20, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr10:43615631
GRCh38:
Chr10:43120183
RETS650A, S904A, S421A, S758A, S808A, S509A, S560A, S562A, S565A, S574A, S662A, S772A, S816A, S469A, S605A, S729A, S859A, S861AHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia, type 2a
Uncertain significance
(Jun 12, 2023)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr10:43600475
GRCh38:
Chr10:43105027
RETR234Q, R138Q, R191QFamilial medullary thyroid carcinoma, not provided, Hereditary cancer-predisposing syndrome,
Multiple endocrine neoplasia, type 2, Familial medullary thyroid carcinoma, Pheochromocytoma,
Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b
Conflicting interpretations of pathogenicity
(May 11, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr10:43613901
GRCh38:
Chr10:43118453
RETK535E, K789E, K445E, K693E, K701E, K459E, K490E, K547E, K306E, K354E, K614E, K643E, K394E, K447E, K450E, K657E, K744E, K746EHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2b, Multiple endocrine neoplasia, type 2a,
Pheochromocytoma, Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2
Conflicting interpretations of pathogenicity
(Nov 18, 2022)
criteria provided, conflicting interpretations
92.
GRCh37:
Chr10:43612104
GRCh38:
Chr10:43116656
RETK483Q, K737Q, K254Q, K302Q, K342Q, K393Q, K649Q, K398Q, K495Q, K605Q, K641Q, K395Q, K407Q, K562Q, K591Q, K438Q, K692Q, K694QMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2b,
Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Familial medullary thyroid carcinoma, not provided
Uncertain significance
(Mar 14, 2023)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr10:43595915
GRCh38:
Chr10:43100467
RETG28SHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, not provided,
Pheochromocytoma, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b
Conflicting interpretations of pathogenicity
(May 31, 2023)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr10:43614996
Chr10:43619149
GRCh38:
Chr10:43119548
Chr10:43123701
RET, RETV804M, V550M, V321M, V460M, V672M, V759M, V369M, V409M, V462M, V658M, V708M, V465M, V505M, V629M, V716M, V474M, V562M, V761M, I944M, I690M, I509M, I602M, I645M, I901M, I600M, I769M, I798M, I812M, I461M, I605M, I614M, I702M, I899M, I549M, I848M, I856MMedullary thyroid carcinomaPathogenic
(Jun 15, 2016)
criteria provided, single submitter
95.
GRCh37:
Chr10:43606667-43606668
GRCh38:
Chr10:43111219-43111220
RETV173fs, V427fsSensorineural hearing impairment, Hirschsprung disease, susceptibility to, 1Pathogenic
(Nov 6, 2018)
criteria provided, single submitter
96.
GRCh37:
Chr10:43600426
GRCh38:
Chr10:43104978
RETP218S, P122S, P175SMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2a,
Hirschsprung disease, susceptibility to, 1, Pheochromocytoma, Multiple endocrine neoplasia, type 2a,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2b
Uncertain significance
(Jun 9, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr10:43612057
GRCh38:
Chr10:43116609
RETR721Q, R467Q, R286Q, R377Q, R479Q, R625Q, R379Q, R391Q, R589Q, R676Q, R326Q, R422Q, R678Q, R238Q, R382Q, R546Q, R575Q, R633QHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, not provided,
Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a
Uncertain significance
(Jul 25, 2023)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr10:43617418
GRCh38:
Chr10:43121970
RETA919P, A665P, A620P, A677P, A744P, A787P, A575P, A577P, A580P, A589P, A831P, A436P, A773P, A484P, A524P, A823P, A874P, A876PMultiple endocrine neoplasia, type 2, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b,
Familial medullary thyroid carcinoma, Pheochromocytoma, Multiple endocrine neoplasia, type 2a,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 6, 2023)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr10:43610177
GRCh38:
Chr10:43114729
RETK710R, K456R, K227R, K380R, K564R, K614R, K366R, K371R, K411R, K535R, K275R, K315R, K578R, K368R, K468R, K622R, K665R, K667RMultiple endocrine neoplasia, Pheochromocytoma, Hereditary cancer-predisposing syndrome,
Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia, type 2b, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1,
Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2Renal hypodysplasia/aplasia 1,
...see more
Uncertain significance
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr10:43597885
GRCh38:
Chr10:43102437
RETV145IHereditary cancer-predisposing syndrome, Congenital central hypoventilation, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Familial medullary thyroid carcinoma,
Multiple endocrine neoplasia, type 2a, not provided, Multiple endocrine neoplasia, type 2
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination